Difference between revisions of "Team:Pumas Mexico/Parts"

 
Line 249: Line 249:
  
  
−
<p>Each team will make new parts during iGEM and will submit them to the Registry of Standard Biological Parts. The iGEM software provides an easy way to present the parts your team has created. The <code>&lt;groupparts&gt;</code> tag (see below) will generate a table with all of the parts that your team adds to your team sandbox.</p>
+
<p>  
−
<p>Remember that the goal of proper part documentation is to describe and define a part, so that it can be used without needing to refer to the primary literature. Registry users in future years should be able to read your documentation and be able to use the part successfully. Also, you should provide proper references to acknowledge previous authors and to provide for users who wish to know more.</p>
+
Las biopartes que se presentan a continuación fueron diseñadas a partir de genes en otras organismos. En este caso, homólogos de Saccharomyces cerevisiae en Chlamydomonas reinhardtii, para su aplicación en Chlorella vulgaris, y de C. reinhardtii a C. vulgaris. <br>Offer an alternative of viable energy for our current social dynamics was our main ímpetus to carry out our first objective: desig a strain of C. vulgaris with the ability to secrete lipid to the medium and that it has a superior in comparison to storage of wild type (WT).<br>
 +
<groupparts> <br>
 +
DGTT1 Is a gene present in Chlamydomonas reinhardtii, is responsible for the production of lipids. De facto, Chlorella vulgaris already has a regulation of production, however, with this is obtained a great improvement with regard to quality. The lipid profile is mediated by the medium wich is. <br> To avoid the formation of bodies that sweeps the replication of DNA in Chlorella use a vector, plasmid pCAMBIA 1301, constituting, with a strong promoter.In this case, incerted in the GUS section, after enzymatic digestión of both (GUS of pCAMBIA and puCIDT-Kan GATA:6 in DGTT1). Synthesis of our part of interest was conducted by the Integrated DNA Technologies.
 +
 
 +
</p>
  
  
Line 262: Line 266:
 
<div class="highlight">
 
<div class="highlight">
 
<h5>Note</h5>
 
<h5>Note</h5>
−
<p>Note that parts must be documented on the <a href="http://parts.igem.org/Main_Page"> Registry</a>. This page serves to <i>showcase</i> the parts you have made. Future teams and other users and are much more likely to find parts by looking in the Registry than by looking at your team wiki.</p>
+
<p></p>
 
</div>
 
</div>
 
</div>
 
</div>
Line 271: Line 275:
 
<div class="column half_size">
 
<div class="column half_size">
  
−
<h5>Adding parts to the registry</h5>
+
<h5></h5>
−
<p>You can add parts to the Registry at our <a href="http://parts.igem.org/Add_a_Part_to_the_Registry">Add a Part to the Registry</a> link.</p>
+
<p></p>
−
<p>We encourage teams to start completing documentation for their parts on the Registry as soon as you have it available. The sooner you put up your parts, the better you will remember all the details about your parts. Remember, you don't need to send us the DNA sample before you create an entry for a part on the Registry. (However, you <b>do</b> need to send us the DNA sample before the Jamboree. If you don't send us a DNA sample of a part, that part will not be eligible for awards and medal criteria.)</p>
+
<p></p>
 
</div>
 
</div>
  
Line 282: Line 286:
 
<div class="column half_size">
 
<div class="column half_size">
  
−
<h5>What information do I need to start putting my parts on the Registry?</h5>
+
<h5></h5>
−
<p>The information needed to initially create a part on the Registry is:</p>
+
<p></p>
 
<ul>
 
<ul>
−
<li>Part Name</li>
+
<li></li>
−
<li>Part type</li>
+
<li></li>
−
<li>Creator</li>
+
<li></li>
−
<li>Sequence</li>
+
<li></li>
−
<li>Short Description (60 characters on what the DNA does)</li>
+
<li></li>
−
<li>Long Description (Longer description of what the DNA does)</li>
+
<li></li>
−
<li>Design considerations</li>
+
<li></li>
 
</ul>
 
</ul>
  
−
<p>
 
−
We encourage you to put up <em>much more</em> information as you gather it over the summer. If you have images, plots, characterization data and other information, please also put it up on the part page. </p>
 
  
 
</div>
 
</div>
Line 302: Line 304:
 
<div class="column half_size">
 
<div class="column half_size">
  
−
<h5>Inspiration</h5>
 
−
<p>We have a created  a <a href="http://parts.igem.org/Well_Documented_Parts">collection of well documented parts</a> that can help you get started.</p>
 
  
−
<p> You can also take a look at how other teams have documented their parts in their wiki:</p>
 
−
<ul>
 
−
<li><a href="https://2014.igem.org/Team:MIT/Parts"> 2014 MIT </a></li>
 
−
<li><a href="https://2014.igem.org/Team:Heidelberg/Parts"> 2014 Heidelberg</a></li>
 
−
<li><a href="https://2014.igem.org/Team:Tokyo_Tech/Parts">2014 Tokyo Tech</a></li>
 
 
</ul>
 
</ul>
 
</div>
 
</div>

Latest revision as of 01:00, 20 October 2016

Pumas_Mexico



Las biopartes que se presentan a continuación fueron diseñadas a partir de genes en otras organismos. En este caso, homólogos de Saccharomyces cerevisiae en Chlamydomonas reinhardtii, para su aplicación en Chlorella vulgaris, y de C. reinhardtii a C. vulgaris.
Offer an alternative of viable energy for our current social dynamics was our main ímpetus to carry out our first objective: desig a strain of C. vulgaris with the ability to secrete lipid to the medium and that it has a superior in comparison to storage of wild type (WT).

DGTT1 Is a gene present in Chlamydomonas reinhardtii, is responsible for the production of lipids. De facto, Chlorella vulgaris already has a regulation of production, however, with this is obtained a great improvement with regard to quality. The lipid profile is mediated by the medium wich is.
To avoid the formation of bodies that sweeps the replication of DNA in Chlorella use a vector, plasmid pCAMBIA 1301, constituting, with a strong promoter.In this case, incerted in the GUS section, after enzymatic digestión of both (GUS of pCAMBIA and puCIDT-Kan GATA:6 in DGTT1). Synthesis of our part of interest was conducted by the Integrated DNA Technologies.

Note

Part Table
<groupparts>iGEM2016 Example</groupparts>